I have a query -
-
What will be the effect on shareholders of Shilpa Medicare as management is transferring the API business of the company by way of slump sale as “going concern” to Shilpa Lifesciences Private Limited ?
-
Slump Sale shall unlock the value for API business, but it wont give any benefit to shareholders of Shilpa Med, as shareholders wont get anything here?
-
What if the management had de-merged the API business, thereby creating more value for its current shareholders. Current shareholders could have got shares of new company (de-merged entity), So is the decision of slump sale detrimental to the interest of current shareholders of Shilpa Medicare ??
-
What will be the effect on Share Price on Shilpa after slump sale ?
need to know opinion of learned members here.